ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1731

Radiographic Damage of Facet Joints and Vertebral Bodies in the Cervical Spine in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors

Fiona Maas1, Suzanne Arends1, Elisabeth Brouwer1, Eveline van der Veer2, Hendrika Bootsma1, Rizwana Chaudhry1, Monique Efde3, Freke Wink3 and Anneke Spoorenberg1, 1Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 2Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 3Rheumatology, Medical Center Leeuwarden, Leeuwarden, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Ankylosing spondylitis (AS), anti-TNF therapy, radiography and spine involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Comorbidities and Treatment Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In ankylosing spondylitis (AS), syndesmophyte formation and ankylosis of the vertebral bodies are characteristic radiographic changes that are evaluated during follow-up. However, the facet joints are also involved in the disease process. Our aim was to investigate the prevalence and incidence of radiographic facet joint involvement in comparison to damage of vertebral bodies in the cervical spine of AS patients treated with TNF-α inhibitors. Second, to explore the association of facet joint involvement with patient characteristics and clinical outcome.

Methods: Consecutive patients from the Groningen Leeuwarden AS (GLAS) cohort who started treatment with TNF-α inhibitors because of active disease were included. Available lateral radiographs of the cervical spine at baseline and after 4 years of follow-up were scored by two trained and independent readers blinded to patient characteristics and time sequence. Facet joints of C2-C3 up to C6-C7 were scored according to the method of de Vlam et al. (0: normal, 1: joint space narrowing or erosion, 2: partial blurring or ankylosis, 3: complete blurring or ankylosis). Definite damage and progression of facet joints was defined as the presence and development of partial/complete blurring or ankylosis (score ≥2) in ≥1 facet joint, respectively. The modified Stoke AS Spine Score (mSASSS) was used to assess radiographic damage of the vertebral bodies. Definite damage and progression was defined as the presence and development of ≥1 (bridging) syndesmophyte, respectively.

Results: Of 108 included patients, 76% were male, mean age was 43±11 years, median symptom duration 17 years (range 1-50), 84% were HLA-B27 positive, mean BASDAI was 5.9±1.7, and mean ASDAS 3.8±0.8.

At baseline, 28 (26%) patients had definite damage of facet joints with on average 3 facet joints involved. Fifty-nine (55%) patients had definite damage of vertebral bodies. Damage of facet joints exclusively occurred in 5 (5%) patients. Patients with damage of facet joints were more frequently male, older, had longer symptom duration, more frequently a history of psoriasis, larger occiput-to-wall distance, and higher mSASSS of the cervical spine (all p<0.05).

After 4 years of follow-up, 13 (12%) patients showed definite progression of facet joints and 28 (26%) showed definite progression of vertebral bodies. Progression of facet joints without progression of vertebral bodies was seen in 8 (7%) patients.

Conclusion: In this observational cohort of AS patients with active disease, 26% had radiographic damage of facet joints whereas 55% had damage of vertebral bodies. Damage of facet joints was associated with male gender and more advanced disease. During 4 years of TNF-α blocking therapy, 12% showed definite progression of facet joints. More than half of these patients did not show progression of vertebral bodies.


Disclosure: F. Maas, None; S. Arends, Pfizer Inc, 2,Abbvie, 2; E. Brouwer, Abbvie, 2,Pfizer Inc, 2; E. van der Veer, None; H. Bootsma, Roche Pharmaceuticals, 2,Bristol-Myers Squibb, 2; R. Chaudhry, None; M. Efde, None; F. Wink, Abbvie, 5; A. Spoorenberg, Abbvie, 2,Pfizer Inc, 2,Abbvie, 5,Pfizer Inc, 5,UCB, 5.

To cite this abstract in AMA style:

Maas F, Arends S, Brouwer E, van der Veer E, Bootsma H, Chaudhry R, Efde M, Wink F, Spoorenberg A. Radiographic Damage of Facet Joints and Vertebral Bodies in the Cervical Spine in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/radiographic-damage-of-facet-joints-and-vertebral-bodies-in-the-cervical-spine-in-patients-with-ankylosing-spondylitis-treated-with-tnf-inhibitors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/radiographic-damage-of-facet-joints-and-vertebral-bodies-in-the-cervical-spine-in-patients-with-ankylosing-spondylitis-treated-with-tnf-inhibitors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology